Alberta Investment Management Corp Purchases New Shares in Addus HomeCare Co. (NASDAQ:ADUS)

Alberta Investment Management Corp acquired a new stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 16,882 shares of the company’s stock, valued at approximately $2,116,000. Alberta Investment Management Corp owned approximately 0.09% of Addus HomeCare at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Quarry LP bought a new position in shares of Addus HomeCare in the third quarter valued at approximately $28,000. Farther Finance Advisors LLC lifted its stake in Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after purchasing an additional 366 shares during the last quarter. KBC Group NV grew its holdings in Addus HomeCare by 49.1% during the fourth quarter. KBC Group NV now owns 814 shares of the company’s stock valued at $102,000 after purchasing an additional 268 shares during the period. Assetmark Inc. grew its holdings in Addus HomeCare by 11.5% during the third quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock valued at $156,000 after purchasing an additional 121 shares during the period. Finally, GAMMA Investing LLC increased its position in Addus HomeCare by 34.5% in the fourth quarter. GAMMA Investing LLC now owns 1,258 shares of the company’s stock worth $158,000 after buying an additional 323 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $109.23 on Friday. The company has a market capitalization of $1.98 billion, a price-to-earnings ratio of 25.00, a PEG ratio of 1.46 and a beta of 1.00. The business has a 50 day moving average of $125.04 and a 200 day moving average of $126.75. Addus HomeCare Co. has a 1-year low of $85.94 and a 1-year high of $136.72.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the completion of the transaction, the chief executive officer now owns 79,397 shares in the company, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 39,750 shares of company stock valued at $4,930,750. 4.60% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. Oppenheimer boosted their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research report on Friday, January 24th. StockNews.com upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Friday, January 24th. Stephens raised their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. Macquarie reiterated an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a research report on Monday, November 4th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, eight have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $134.22.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.